21 results about "Preterm delivery" patented technology

There is provided a computer system and a computer-implemented method for prediction of parameters indicative of the risk of spontaneous preterm birth (sPTB) for a subject under assessment, the method being executed by at least one hardware processor and comprising the steps of: providing one or more ultrasound images comprising medical image data representative of the anatomical structure and appearance of at least a part of a cervix of the subject; providing a plurality of segmentations of the medical image data each representative of one or more features of the anatomical structure and appearance of the at least a part of the cervix of the subject; and utilizing i) the medical image data, ii) spatial information associated with the medical image data and iii) one or more of the segmentations in a classifier model to determine a prediction metric indicative of the likelihood of sPTB for the subject.

The invention discloses a system, method and device for premature delivery risk prediction and a storage medium, and belongs to the technical field of biomedical information. The system comprises a data acquisition module and a data processing device. The data acquisition module is used for acquiring hemoglobin concentration, serum ferritin concentration, age, BMI, pregnancy times, delivery times, marriage conditions, education degree and other clinical characteristic data of the pregnant woman in the early pregnancy period, the middle pregnancy period and the late pregnancy period; the input characteristics of the model comprise all data of the three stages of pregnancy; the risk score is then compared with a specific threshold value set based on a Youden index, and a risk level of preterm delivery, spontaneous preterm delivery, or iatrogenic preterm delivery is output. The Hb-SF-Clinical multi-feature prediction model is constructed by fusing the three-stage pregnancy dynamic biomarkers and clinical features, the AUC (early birth prediction) of the Hb-SF-Clinical multi-feature prediction model in a test set reaches up to 96.0%, the Hb-SF-Clinical multi-feature prediction model is remarkably superior to the prior art, high-precision and subtype early birth risk assessment is realized, and the clinical applicability is high.

Systems, devices, and methods are provided that control, support, and / or elongate a cervix to treat pregnancy complications and / or delay an onset of labor so that a gestational period for a fetus may be extended, thereby preventing preterm labor and delivery of the fetus. The systems and devices may be made by assembling a molded component configured to have a main body with a groove therein and a flange. During manufacturing, the flange may be inserted into the groove and bonded therein to form a cervical cuff balloon and a positioning balloon may be attached to an external surface of the main body. The molded component may further include an inflation media conduit in communication with the cervical cuff balloon.

Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

A system, device, and method of controlling, supporting, and / or elongating the cervix uteri are provided to treat gestation complications and / or delay the onset of childbirth such that the gestation period of a fetus can be extended to prevent preterm birth and childbirth of the fetus. A cervical control system may include a body configured to be placed in the vagina. The body has an internal channel configured for receiving a cervix therein and an inflatable and / or inflatable inner cuff extending from a portion of the internal channel. The inner cuff may inflate inwardly toward the cervix, or downwardly away from the cervix, or both inwardly and downwardly, such that the inner cuff may engage or clamp the cervix to secure the cervix control system in place while pressing the cervix to close, elongate, and / or adjust the cervix orientation angle.

The invention provides an intelligent prediction system and method for prenatal complications of an obstetrical department based on multi-modal fusion of sclera characteristics and clinical indexes, and is applied to the technical field of data processing. The method comprises the following steps: performing preprocessing and fusion calculation on feature information in multi-modal data to generate fusion calculation data; the prenatal complications (such as gestational diabetes mellitus, gestational hypertension, premature rupture of fetal membranes and premature delivery) of the obstetrics department are dynamically predicted, and prediction characteristic parameters are generated; performing abnormal value filtering processing on the cross-modal feature weight, dynamically optimizing the weight in combination with a clinical and image feature correlation matrix, and generating feature weight data; processing the feature weight data to generate feature importance dynamic change data and abnormal features; processing the feature importance dynamic change data based on a preset risk judgment rule and the abnormal features to generate risk judgment data; and processing the risk judgment data and the prediction characteristic parameters to generate risk early warning information and a complication intervention instruction.

Aspects of the present disclosure provide, inter alia, a novel nutritional formula for infants and toddlers. Also provided are methods for promoting development of infants and toddlers, such as development of the brain, eye and / or immune system, including in preterm infants.

The present invention relates generally to the field of compositions comprising myo-inositol for use in the prevention of preterm birth and / or of conditions linked to preterm delivery in a female subject and / or in the offspring. The composition may be a nutritional composition, for example a maternal nutrition composition. The composition may be specifically designed to provide optimized nutrition to a woman desiring to get pregnant or to a pregnant woman.

An insulin formulation and a method of preparing and using same. The insulin preparation includes insulin, oligosaccharide and sodium chloride at a ratio of 1:A:B (w:w:w respectively) with ranges of A and B are 1000-5000 and 10-50, respectively.

A device for retarding birth including an upper ring for surrounding a cervix, an anchoring component for anchoring the device, and an elastic component for attaching the upper ring to the anchoring component, wherein the elastic component pushes the upper ring and the anchoring component apart. A device for retarding birth including a sleeve for surrounding a cervix along a greater portion of a length of the cervix, a support strip on the sleeve directed along an axis of the sleeve, and a ring at least partially around the sleeve, in which when a top of the sleeve is pushed to expand radially, the support strip pivots on the ring, such that an end of the support strip near the top of the sleeve moves radially outward, and an end of the support strip near the bottom of the sleeve moves radially inward. Related apparatus and methods are also described.

Provided are a novel biomarker for predicting preterm birth and an analysis method therefor. This biomarker for predicting preterm birth is at least one selected from the group consisting of oleic acid, myristic acid, lauric acid, margaric acid, and batyl alcohol in amniotic fluid.

Provided are methods of predicting the likelihood of preterm birth (PTB) or early preterm birth (ePTB) for a subject. The methods comprise performing 16S rRNA gene sequencing on vaginal fluid sample DNA to obtain vaginal microbiome 16S rRNA gene sequencing data, and harmonizing the vaginal microbiome 16S rRNA gene sequencing data. The methods further comprise transforming the harmonized vaginal microbiome 16S rRNA gene sequencing data into vaginal microbiome features, inputting the vaginal microbiome features into a predictive model, and predicting, using the predictive model, the likelihood of PTB or ePTB for the subject from whom the vaginal fluid sample was obtained. Computer readable media and systems that find use in practicing the methods of the present disclosure are also provided.

A cervix probe is equipped with a tactile sensor array and an ultrasound transducer and configured for simultaneous acquisition of stress data and ultrasound strain data for the same sector of the cervix. Acquired and recorded stress and strain data are transmitted to a data processor for calculating cervix elasticity and cervix length, followed by calculating a probability of spontaneous preterm delivery using a clinically validated predictive model.

Provided is a method of preventing and treating an onset of preterm labor and preterm birth, promoting fetal lung development, and reversing inflammation and reducing stress in the uterine environment by administering a pharmaceutically effective amount of Nestorone® (NES) to a pregnant individual in need thereof.

A system for providing information for diagnosing preterm birth risk includes: two or more transmit electrodes, contacting cervical tissues, for applying a plurality of first signals at different frequencies to the cervical tissues, two or more detect electrodes, contacting the cervical tissues, for detecting a plurality of second signals generated in response to the first signals, the second signals corresponding to the first signals, and a source configured to generate a plurality of signals. The system obtains a plurality of impedances of the cervical tissues based on the first and the second signals and applies data quality requirements for diagnosing the preterm birth risk. The data quality requirements include checking at least one of signal generation, signal reception, impedance calculation, quality of the first signals, quality of the second signals, and the impedances. The system includes a diagnosis engine configured to receive data including impedances that satisfy the data quality requirements, classify the data into different groups, each representing different status, based on correlation between the data, patient's information and the preterm birth risk, and output information for diagnosing the preterm birth risk.

A cervical cup includes a flexible body having a flange to treat preterm birth, the cervical cup being configured to apply suction pressure to the cervix of a patient by compressing the flexible body and holding the flange against the pelvic floor of a patient being treated for preterm birth, the suction pressure being generated by the release of the compression applied to the flexible body. An example of the disclosed methodology to treat preterm birth includes inserting a cervix into a cervical cup and applying a vacuum thereto so as to secure the cervical cup to the cervix.

An orally active, brain penetrant first-in-class small molecule midkine inhibitor for use in the treatment of triple-negative breast cancer, brain tumors (including glioblastoma, medulloblastoma, and NF1-mutant optic pathway gliomas), ovarian and endometrial cancers, lung cancer, as well as gynecologic non-malignant conditions such as endometriosis, uterine fibroids, and preterm birth, in which tumor cells and / or pathological cells exhibit heightened midkine signaling and express multiple midkine receptors.

Systems and methods are disclosed relating to extracorporeal fetal care. A fetal chamber assembly configured to enclose and support a fetus therein includes a base configured to receive the fetus therein; a lid configured to removably contact the base to form a liquid-tight seal between the lid and the base; a growth chamber defined between the base and the lid, the growth chamber being configured to receive the fetus therein; and a cannulation chamber in fluid communication with the growth chamber, the cannulation chamber being configured to receive therein a cannulated umbilical cord of the fetus. The growth chamber is configured to be adjusted in size to accommodate the fetus during gestation based on the size of the fetus, and the fetal chamber assembly is configured to receive a liquid from a liquid source.

The invention relates to the field of medicine, namely to ophthalmology, and can be used in the combined treatment of active retinopathy of prematurity type 1 in zone 1, in children with a gestational age of less than 28 weeks. The technical objective is to develop an effective method for the combined treatment of active retinopathy of prematurity type 1 in zone 1, in children with a gestational age of less than 28 weeks, by performing simultaneous transpupillary laser coagulation of the retina only in the nasal quadrants and introducing an angiogenesis inhibitor into the vitreous cavity. The proposed method solves this problem, involving simultaneous transpupillary laser photocoagulation of avascular zones of the retina in the nasal quadrants only and the injection of an angiogenesis inhibitor into the vitreous cavity. This method prevents the development of tractional retinal detachment, which causes blindness and low vision in children, reactivation of active ROP, and postoperative uveitis, which require additional surgical treatment, in 100% of cases.

Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.

A cervical probe, equipped with both a tactile sensor array and an ultrasound transducer array, is engineered for the simultaneous acquisition of stress and ultrasound strain data from cervical sectors, as well as for the measurement of cervical length. The collected stress and strain data from various cervical sectors are transmitted to a data processor. This processor calculates cervical elasticity using a strain-to-stress ratio. Subsequently, the arithmetic mean of the stress-to-strain ratios is compared with a predetermined cutoff value, and the measured cervical length is evaluated against another predetermined value, to predict preterm birth during gestational weeks 24-28.